10 Aug 2023 , 10:56 AM
Result date: 11th August, 2023
Recommendation: Buy
Target price: Rs. 5,550
Analysts at IIFL Securities Apollo Hospitals Enterprise could witness decline in patient occupancies. However, continued traction in ARPOB (Average Revenue Per Occupied bed) could aid growth in revenue. Growth in realization is likely to be driven by an improving payer and specialty mix. The company’s revenue could grow 19% over the year-ago quarter and 5% sequentially.
Apollo Hospitals Enterprise could post about 5% growth in EBITDA, both over the year-ago quarter as well as sequentially. However, analysts at IIFL Securities expect increase in EBITDA losses of the 24/7 business to Rs. 2 Billion in the quarter under review, which will restrict the company’s overall consolidated EBITDA growth.
The company’s Profit After Tax or PAT could grow 7.3% over the year-ago quarter and 26.6% sequentially.
June 2023 estimates |
QoQ change |
YoY change |
|
Bed occupancy (%) |
62.9% |
(36) bps |
345 bps |
ARPOB (Rs ‘000 per day) |
54.8 |
3.0% |
6.8% |
Revenue (Rs. mn) |
45,149 |
4.9% |
19.0% |
EBITDA (Rs. mn) |
5,150 |
5.5% |
4.9% |
EBITDA margin |
11.4% |
6 bps |
(152) bps |
Profit After Tax (Rs. mn) |
1,829 |
26.6% |
7.3% |
Source: IIFL Research
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice